Effect of epigenetic modification of maspin on extravillous trophoblastic function

Abstract

This study investigated the effect of epigenetic modification of maspin on extravillous trophoblastic function. The mRNA expression of maspin in placentae from normotensive and preeclamptic pregnant women was detected by RT-PCR. TEV-1 cells, a human first-trimester extravillous trophoblast cell line, were cultured and treated with CoCl₂ (300 μmol/L) to induce chemical hypoxia and with 5-aza (500 nmol/L) to induce demethylation. The mRNA expression of maspin in TEV-1 cells subjected to different treatments was determined by RT-PCR, and the proliferative and migratory abilities of TEV-1 cells were assessed by cell counting kit-8 (CCK-8) and Transwell assays. Our results showed that the maspin mRNA expression level in placentae from preeclamptic women was much higher than that from normotensive women. CoCl₂ or 5-aza could up-regulate the mRNA expression of maspin and significantly suppress the proliferation and migration of TEV-1 cells. It was concluded that the epigenetic modification in promoter region of maspin contributes to incomplete trophoblast invasion, which offers a novel approach for predicting and treating placental dysfunction.

Keywords

maspin / preeclampsia / TEV-1 / hypoxia / methylation / proliferation / migration

References

[1] ZouZ., AnisowiczA., HendrixM.J., et al.. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science, 1994, 263(5146): 526-529

[2] LiuJ., YinS., ReddyN., et al.. Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res, 2004, 64(5): 1703-1711

[3] NarayanM., TwiningS.. Focus on molecules: maspin. Exp Eye Res, 2010, 90(1): 2-3

[4] Khalkhali-EllisZ.. Maspin: the new frontier. Clin Cancer Res, 2006, 12(24): 7279-7283

[5] MaassN., NagasakiK., ZiebartM., et al.. Expression and regulation of tumor suppressor gene maspin in breast cancer. Clin Breast Cancer, 2002, 3(4): 281-287

[6] DomannF.E., RiceJ.C., HendrixM.J.C., et al.. Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer, 2000, 85(6): 805-810

[7] CountsJ.L., GoodmanJ.I.. Hypomethylation of DNA: an epigenetic mechanism involved in tumor promotion. Mol Carcinog, 1994, 11(4): 185-188

[8] RoseS.L., FitzgeraldM.P., WhiteN.O., et al.. Epigenetic regulation of maspin expression in human ovarian carcinoma cells. Gynecol Oncol, 2006, 102(2): 319-324

[9] DokrasA., GardnerL.M., KirschmannD.A., et al.. The tumour suppressor gene maspin is differentially regulated in cytotrophoblasts during human placental development. Placenta, 2002, 3(4): 274-280

[10] LiH.W., LeungS.W., CheungA.N., et al.. Expression of maspin in gestational trophoblastic disease. Gynecol Oncol, 2006, 101(1): 76-81

[11] FengH.C., ChoyM.Y., DengW., et al.. Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1). J Soc Gynecol Investig, 2005, 12(4): e21-e32

[12] SoodA.K., FletcherM.S., GrumanL.M., et al.. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res, 2002, 8(9): 2924-2932

[13] McKenzieS., SakamotoS., KyprianouN.. Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT. Oncogene, 2008, 27(57): 7171-7179

[14] EitelJ.A., Bijangi-VishehsaraeiK., SaadatzadehM.R., et al.. PTEN and p53 are required for hypoxia induced expression of maspin in glioblastoma cells. Cell Cycle, 2009, 8(6): 896-901

[15] CaiZ., ZhouY., LeiT., et al.. Mammary serine protease inhibitor inhibits epithelial growth factor-induced epithelial-mesenchymal transition of esophageal carcinoma cells. Cancer, 2009, 115(1): 36-48

[16] ZhouQ., LiuH., QiaoF., et al.. VEGF deficit is involved in endothelium dysfunction in preeclampsia. J Huazhong Univ Sci Technolog Med Sci, 2010, 30(3): 370-374

[17] ZhouQ., QiaoF.Y., ZhaoC., et al.. Hypoxic trophoblast-derived sFlt-1 may contribute to endothelial dysfunction: implication for the mechanism of trophoblast-endothelial dysfunction in preeclampsia. Cell Biol Int, 2011, 35(1): 61-66

[18] WozniakR.J., KlimeckiW.T., LauS.S., et al.. 5-Aza-2’-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Oncogene, 2007, 26(1): 77-90

[19] WuY., AlvarezM., SlamonD.J., et al.. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. BMC Cancer, 2010, 10: 32

[20] FujisawaK., MaesawaC., SatoR., et al.. Epigenetic status and aberrant expression of the maspin gene in human hepato-biliary tract carcinomas. Lab Invest, 2005, 85(2): 214-224

[21] BettstetterM., WoenckhausM., WildP.J., et al.. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer. J Pathol, 2005, 205(5): 606-614

[22] MuraiS., MaesawaC., MasudaT., et al.. Aberrant maspin expression in human endometrial cancer. Cancer Sci, 2006, 97(9): 883-888

[23] Alvarez SecordA., DarcyK.M., HutsonA., et al.. The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study. Gynecol Oncol, 2011, 123(2): 314-319

[24] OhikeN., MaassN., MundhenkeC., et al.. Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. Cancer Lett, 2003, 199(2): 193-200

[25] FitzgeraldM., OshiroM., HoltanN., et al.. Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control. Neoplasia, 2003, 5(5): 427-436

[26] SatoN., FukushimaN., MatsubayashiH., et al.. Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene, 2004, 23(8): 1531-1538

[27] SugimotoS., MaassN., TakimotoY., et al.. Expression and regulation of tumor suppressor gene maspin in human bladder cancer. Cancer Lett, 2004, 203(2): 209-215

[28] MurakamiJ., AsaumiJ., MakiY., et al.. Effects of demethylating agent 5-aza-2(′)-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines. Oral Oncol, 2004, 40(6): 597-603

[29] WadaK., MaesawaC., AkasakaT., et al.. Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells. J Invest Dermatol, 2004, 122(3): 805-811

[30] ZhangM., VolpertO., ShiY.H., et al.. Maspin is an angiogenesis inhibitor. Nat Med, 2000, 6(2): 196-199